Merck & Co Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (203)

Latest Posts

About This Stock More About This Stock
Merck: Surpasses Q1 Earnings And Revenue Estimates
Article By: Zacks Investment Research
Thursday, April 27, 2023 6:50 AM EDT
Merck came out with quarterly earnings of $1.40 per share.
In this article: MRK
Read
Moderna, Merck, And A Personalized Cancer Vaccine - Updates From AACR
Article By: Bio Deep Dives
Sunday, April 16, 2023 4:39 PM EDT
Moderna and Merck presented additional data on their personalized mRNA cancer vaccine. Is this a true breakthrough in cancer vaccines?
In this article: MRNA, MRK
Read
MRK: Chart Of The Week
Video By: Bob Lang
Thursday, April 13, 2023 4:00 PM EDT
The 20-day moving average is coming in at about 170 – 172, which is 6 above where the current price level is.
In this video: MRK
Watch
Secrets Of Great Long-Term Stock Investors
Video By: Tracey Ryniec
Sunday, March 5, 2023 5:57 PM EDT
What can the rest of us learn from Warren Buffett's long-term stock buys? Here are 5 stock ideas for long-term investors.
In this video: AXP, CVX, KO, MRK, COKE Also: VOO, BRK-A
Watch
Merck Beats Earnings Estimates
Video By: CNBC
Thursday, February 2, 2023 9:19 AM EDT
Merck came out with quarterly earnings of $1.62 per share.
In this video: MRK
Watch

Latest Tweets for $MRK

No tweets yet!

PARTNER HEADLINES

$MRK

OncoSec Raising Its Profile In Fight Against Cancer
Harry Goldstein 9/7/2017 5:43:14 PM

I appreciate a promising investment that also helps people. Bullish on $ONCS and $MRK.

OncoSec Raising Its Profile In Fight Against Cancer
Alexis Renault 9/6/2017 4:08:15 PM

Thanks for this info, @[Terry Chrisomalis](user:5023). Is there any sort of official partnership or cooperation between #OncoSecMedical and #Merck to use ImmunoPulse IL-12 technology in conjunction with #Keytruda? $ONCS $MRK

OncoSec Raising Its Profile In Fight Against Cancer
Dick Kaplan 9/6/2017 4:03:09 PM

Very impressed with the #OncosSec trial results. $ONCS $MRK $BMY

1 to 3 of 3 comments